Evidence map›Paper›PMID 40214695›Full record

ArticleAbdominal radiology (New York)2025

A case of plasmacytoid urothelial carcinoma with characteristic radiological findings.

Fumiko Yagi, Hirotaka Akita, Kazuhiro Matsumoto, Takeo Kosaka, Akihisa Ueno, Shunsuke Nakamura, Yuki Hasunuma, Tomo Taketani, Hajime Okita, Mototsugu Oya and 1 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Abdominal radiology (New York), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Fumiko YagiDepartment of Diagnostic Radiology, Keio University School of Medicine, Tokyo, Japan. fumikoyagi@rad.med.keio.ac.jp.
Hirotaka AkitaDepartment of Diagnostic Radiology, Keio University School of Medicine, Tokyo, Japan.
Kazuhiro MatsumotoDepartment of Urology, Keio University School of Medicine, Tokyo, Japan.
Takeo KosakaDepartment of Urology, Keio University School of Medicine, Tokyo, Japan.
Akihisa UenoDivision of Diagnostic Pathology, Keio University School of Medicine, Tokyo, Japan.
Shunsuke NakamuraDepartment of Diagnostic Radiology, Keio University School of Medicine, Tokyo, Japan.
Yuki HasunumaDepartment of Diagnostic Radiology, Keio University School of Medicine, Tokyo, Japan.
Tomo TaketaniDepartment of Diagnostic Radiology, Keio University School of Medicine, Tokyo, Japan.
Hajime OkitaDivision of Diagnostic Pathology, Keio University School of Medicine, Tokyo, Japan.
Mototsugu OyaDepartment of Urology, Keio University School of Medicine, Tokyo, Japan.
Masahiro JinzakiDepartment of Diagnostic Radiology, Keio University School of Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plasmacytoid urothelial carcinoma (PUC) is a rare and an aggressive subtype of invasive urothelial carcinoma, often diagnosed at advanced stages with poor prognosis. We report a case of PUC with characteristic radiological findings. A male patient in his 70s presented with nocturnal urinary incontinence; cystoscopy findings suggested cancer. Magnetic resonance imaging (MRI) revealed a 6-mm-sized protruding lesion of the bladder with early contrast enhancement and diffusion restriction, indicative of bladder cancer. Additionally, a diffuse bladder wall thickening, abnormal signal intensity, and contrast enhancement were observed around the bladder. Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography showed no significant FDG uptake in the lesion. The possibility of peritoneal dissemination of gastrointestinal malignancy was considered; however, no obvious primary lesions were identified. PUC was suggested as a differential diagnosis, prompting random bladder biopsies during resection of a protruding lesion in the bladder. Immunohistochemical staining confirmed PUC, with positivity for CD138, CK7, and GATA3 and negativity for CDX-2 and E-cadherin. Following treatment with gemcitabine and cisplatin, the lesion size decreased. Diagnosis of PUC can be difficult because the lesion is not easily detected by cystoscopy, misdiagnosed as peritoneal dissemination of gastrointestinal cancer on CT or MRI, or histopathologically similar to plasmacytoma or malignant lymphoma. PUC may present with pelvic peritoneal spread of the tumor as thick sheets extending along the fascial planes, which may be a characteristic imaging finding. Radiologists must be aware of these typical imaging findings to ensure accurate diagnosis of PUC.

Indexed as

Carcinoma, Transitional CellMagnetic Resonance ImagingUrinary Bladder NeoplasmsAgedContrast MediaDiagnosis, DifferentialFluorodeoxyglucose F18HumansMalePositron Emission Tomography Computed TomographyRadiopharmaceuticalsContrast MediaFluorodeoxyglucose F18RadiopharmaceuticalsBladder carcinomaDiffuse bladder wall thickeningLower urinary tract symptomsPlasmacytoid urothelial carcinoma

Identifiers

PMID40214695

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.